GCB

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is GCB's primary investment focus based on its portfolio?

GCB's primary investment focus is in the Health Tech & Life Sciences sector, as indicated by its sole portfolio company, Epitomee Medical, and its only recorded investment round.

Which company is a notable portfolio company for GCB?

Epitomee Medical is a notable portfolio company for GCB. According to startupim data, Epitomee Medical was founded in 2005 and has raised $77M.

When did GCB make its first recorded investment?

GCB made its first recorded investment in April 2019.

What was the investment amount for GCB's first recorded investment?

GCB invested $8,000,000 in Epitomee Medical in April 2019.

Has GCB acted as a lead investor in any of its recorded rounds?

No, GCB has not acted as a lead investor in its recorded investment in Epitomee Medical.

Has GCB had any exits from its portfolio companies?

Yes, GCB had an exit in December 2021 when Epitomee Medical went public on the TASE with a valuation of $203M, having raised $60M in capital.

What is GCB's investment range based on available data?

GCB's investment range, based on the single recorded investment, is $8M.

In which country is GCB headquartered?

GCB is headquartered in Ireland.